A Study of PER-001 in Participants With Open-Angle Glaucoma
Clinical trial NCT05822245 · COMPLETED
Trial details
- NCT number
- NCT05822245
- Sponsor
- Perfuse Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-25
- Primary completion
- 2025-04-20
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.